Neurocrine Insider Buying Signals Confidence in Neuro‑Therapeutic Pipeline Growth
Insider buying at Neurocrine signals confidence in its neuro‑psychiatric pipeline and market‑access strategy, suggesting undervalued upside for investors.
4 minutes to read